PDCD1 and cancer: High PD-L1 expression makes tumor cells more sensitive to PD-1/PD-L1 inhibitors, using PD-1 or PD-L1 antibody therapy can stimulate immune cells to “recognize” cancer cells again, thus enhancing their own immunity to attack cancer cells and significantly prolonging patient survival.